Budesonide modified-release capsules.
Budesonide modified-release capsule is an effective form of therapy for the treatment of Crohn's disease located in the distal ileum, ileocecal region, and ascending colon. Because some of the benefit of budesonide therapy results from local effects, this agent will not be very effective in the treatment of patients with extensive colitis or left-side colitis. Budesonide is equal to less effective than prednisolone or prednisone therapy in the treatment of active Crohn's disease, but is associated with fewer glucocorticoids adverse reactions.
Baker
D E
DE
College of Pharmacy, Washington State University, Spokane, WA, USA.
D000284:Administration, Oral; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D019819:Budesonide / Q000008:administration & dosage* / Q000627:therapeutic use; D002214:Capsules; D003424:Crohn Disease / Q000188:drug therapy*; D005938:Glucocorticoids; D006801:Humans
D000893:Anti-Inflammatory Agents; D002214:Capsules; D005938:Glucocorticoids; D019819:Budesonide